Priority Date: 04.11.11 (EP 20110187962)

ADAM22 FOR USE AS A PROGNOSTIC VARIABLE, AND TARGET FOR THERAPY, OF A METASTATIC BREAST CANCER DISEASE

  • Application ID: EP12795354
  • Status: GRANT OF PATENT INTENDED

Applicant

Company dna royal college of surgeons in ireland
Technology Transfer Office

Attorney

no operation time available
858.71
Headquarter in Dublin and 1 office
active in Legal Services

Specialization

This patent has the IPC class G01 (MEASURING; TESTING) PurdyLucey is specialized in G01. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 04.11.2011 - Priority Date (EP 20110187962)
  • 10.05.2013 - Publication A1 (WO2013064699)
  • 10.09.2014 - Publication A1 (EP2773961)

IPC Classification